Walleye Capital’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.3K	Sell	3,031 -1,566,185	-100%	-$4.96M	﹤0.01%	4173
2025 Q4	$5.81M	Buy	1,569,216 +1,250,025	+392%	+$4.04M	0.03%	1035
2025 Q3	$846K	Buy	+319,191	New	+$617K	0.01%	2222
2025 Q1	–	Sell	-80,837	Closed	-$178K	–	4505
2024 Q4	$178K	Buy	+80,837	New	+$189K	﹤0.01%	3846
2024 Q2	–	Sell	-227,630	Closed	-$610K	–	5715
2024 Q1	$610K	Buy	227,630 +13,630	+6%	+$33.1K	0.01%	3023
2023 Q4	$640K	Buy	+214,000	New	+$278K	0.01%	2746
2023 Q2	–	Sell	-12,296	Closed	-$19.6K	–	4623
2023 Q1	$19.6K	Buy	+12,296	New	+$63.5K	﹤0.01%	3406
2022 Q4	–	Sell	-698,343	Closed	-$4.68M	–	3387
2022 Q3	$4.68M	Sell	698,343 -26,111	-4%	-$179K	0.11%	247
2022 Q2	$4.61M	Buy	724,454 +417,773	+136%	+$2.37M	0.13%	190
2022 Q1	$1.42M	Buy	306,681 +145,932	+91%	+$626K	0.04%	479
2021 Q4	$804K	Buy	+160,749	New	+$1.29M	0.03%	713
2020 Q1	–	Sell	-300	Closed	-$18K	–	1225
2019 Q4	$18K	Buy	+300	New	+$13.5K	﹤0.01%	1614
2019 Q3	–	Sell	-529	Closed	-$21K	–	2115
2019 Q2	$25K	Buy	+529	New	+$24.8K	0.02%	1498
2019 Q1	–	Hold	0	–	–	–	1558